4 ms·

> As recent, on-patent drugs, they are very, very expensive ($360/month... Expensive is always relative to one's income. But, to put that number into perspect

> As recent, on-patent drugs, they are very, very expensive ($360/month... Expensive is always relative to one's income. But, to put that number into perspective relative to another medication given for a good night's sleep: I'm the parent of a narcoleptic. The meds to get a good night's sleep, Xyrem, are in the $15k / month range. The recently approved generics are 1/2 that.

raducu 2y ago
> Xyrem, are in the $15k. Xyrem is basically GHB? A 500 ml bottle of GBL used to be what, 50 euros? I know the medication is pharmeceutical grade, but are these people insane?
- juliusgeo 2y ago
  Xyrem is just the brand name for GHB. The company that currently owns the rights (Jazz Pharmaceuticals) pled guilty to felony misbranding in 2011, and in 2013 raised the price by 841%. More recently, in 2017, they sued multiple other companies attempting to produce generics, before settling on an exclusive licensing agreement with one of them. Ironically the headline on their website is "Improving Patients' Lives", but I imagine they aren't reducing the price because Xyrem makes up 74% of total sales [1]. The entire thing reeks of PE--tons of acquisitions. [1] https://en.wikipedia.org/wiki/Jazz_Pharmaceuticals https://en.wikipedia.org/wiki/Jazz_Pharmaceuticals